2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow zaleplon: new trials by email Literature Review of zaleplon trials Research Report on zaleplon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zaleplon in HIV Patients With Depression Zaleplon - HIV/AIDS, Clinical Depression | Phase 2 | Completed | University of Pennsylvania | 20 | 2014-04-03 | 2018-10-16 |
| Study of Sleep-maintenance Activity of 3 Doses of SKP-1041 placebo, SKP-1041 (experimental formulation of zaleplon) - Sleep Disorder, Primary Insomnia | Phase 2 | Completed | Somnus Therapeutics, Inc. | 67 | 2010-05-01 | 2013-02-01 |
Sleep Initiation and Maintenance Disorders (2) · Acquired Immunodeficiency Syndrome (1) · Depressive Disorder, Major (1) · Sleep Wake Disorders (1)
Somnus Therapeutics, Inc. (1) · University of Pennsylvania (1)
United States (1)
Beth E. Safirstein, MD (1) · D. Alan Lankford, PhD (1) · David J. Seiden, MD (1) · Helene A. Emsellem, MD (1) · James K. Walsh, PhD (1) · Jon Freeman, PhD (1) · Matthew Kayser, MD, PhD (1) · Russell Rosenberg, PhD (1) · Steven G. Hull, MD (1)